Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study.

Ector, Geneviève I C G; Huijskens, Elisabeth G W; Blijlevens, Nicole M A; Westerweel, Peter E

Ector, Geneviève I C G; Huijskens, Elisabeth G W; Blijlevens, Nicole M A; Westerweel, Peter E.

Ector GICG; Department of Haematology, Radboud University Medical Centre, Nijmegen, The Netherlands. genevieve.ector@radboudumc.nl.
Huijskens EGW; Department of Clinical Microbiology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Blijlevens NMA; Department of Haematology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Westerweel PE; Department of Haematology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.

Leukemia ; 34(9): 2533-2535, 2020 09.

Article in English | MEDLINE | ID: covidwho-639980

Subject(s)

Coronavirus Infections; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Pandemics; Pneumonia, Viral; Severe Acute Respiratory Syndrome; Betacoronavirus; COVID-19; Humans; Prevalence; Prospective Studies; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Coronavirus Infections / Severe Acute Respiratory Syndrome / Pandemics Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2020 Document Type: Article Affiliation country: S41375-020-0964-0

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google